Accelerate Diagnostics (AXDX) Competitors $1.64 -0.03 (-1.80%) (As of 11/22/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends AXDX vs. BNGO, BLI, HBIO, SEER, KEQU, FEIM, AKYA, MASS, OWLT, and CLIRShould you be buying Accelerate Diagnostics stock or one of its competitors? The main competitors of Accelerate Diagnostics include Bionano Genomics (BNGO), Berkeley Lights (BLI), Harvard Bioscience (HBIO), Seer (SEER), Kewaunee Scientific (KEQU), Frequency Electronics (FEIM), Akoya Biosciences (AKYA), 908 Devices (MASS), Owlet (OWLT), and ClearSign Technologies (CLIR). Accelerate Diagnostics vs. Bionano Genomics Berkeley Lights Harvard Bioscience Seer Kewaunee Scientific Frequency Electronics Akoya Biosciences 908 Devices Owlet ClearSign Technologies Bionano Genomics (NASDAQ:BNGO) and Accelerate Diagnostics (NASDAQ:AXDX) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their community ranking, institutional ownership, media sentiment, dividends, profitability, earnings, analyst recommendations, risk and valuation. Which has more risk & volatility, BNGO or AXDX? Bionano Genomics has a beta of 2.37, suggesting that its stock price is 137% more volatile than the S&P 500. Comparatively, Accelerate Diagnostics has a beta of 0.59, suggesting that its stock price is 41% less volatile than the S&P 500. Do analysts rate BNGO or AXDX? Bionano Genomics presently has a consensus target price of $1.50, indicating a potential upside of 569.64%. Accelerate Diagnostics has a consensus target price of $1.00, indicating a potential downside of 39.02%. Given Bionano Genomics' higher possible upside, research analysts clearly believe Bionano Genomics is more favorable than Accelerate Diagnostics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Bionano Genomics 0 Sell rating(s) 3 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00Accelerate Diagnostics 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50 Do institutionals and insiders hold more shares of BNGO or AXDX? 11.4% of Bionano Genomics shares are held by institutional investors. Comparatively, 17.1% of Accelerate Diagnostics shares are held by institutional investors. 1.4% of Bionano Genomics shares are held by company insiders. Comparatively, 43.6% of Accelerate Diagnostics shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. Does the media prefer BNGO or AXDX? In the previous week, Bionano Genomics had 2 more articles in the media than Accelerate Diagnostics. MarketBeat recorded 2 mentions for Bionano Genomics and 0 mentions for Accelerate Diagnostics. Bionano Genomics' average media sentiment score of -0.04 beat Accelerate Diagnostics' score of -1.00 indicating that Bionano Genomics is being referred to more favorably in the media. Company Overall Sentiment Bionano Genomics Neutral Accelerate Diagnostics Negative Is BNGO or AXDX more profitable? Bionano Genomics has a net margin of -407.34% compared to Accelerate Diagnostics' net margin of -471.83%. Accelerate Diagnostics' return on equity of 0.00% beat Bionano Genomics' return on equity.Company Net Margins Return on Equity Return on Assets Bionano Genomics-407.34% -154.45% -80.78% Accelerate Diagnostics -471.83%N/A -191.66% Does the MarketBeat Community favor BNGO or AXDX? Accelerate Diagnostics received 192 more outperform votes than Bionano Genomics when rated by MarketBeat users. However, 64.03% of users gave Bionano Genomics an outperform vote while only 60.72% of users gave Accelerate Diagnostics an outperform vote. CompanyUnderperformOutperformBionano GenomicsOutperform Votes16264.03% Underperform Votes9135.97% Accelerate DiagnosticsOutperform Votes35460.72% Underperform Votes22939.28% Which has higher valuation & earnings, BNGO or AXDX? Accelerate Diagnostics has lower revenue, but higher earnings than Bionano Genomics. Accelerate Diagnostics is trading at a lower price-to-earnings ratio than Bionano Genomics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBionano Genomics$36.12M0.63-$232.49M-$2.32-0.10Accelerate Diagnostics$12.06M3.41-$61.62M-$2.86-0.57 SummaryBionano Genomics beats Accelerate Diagnostics on 10 of the 18 factors compared between the two stocks. Ad Behind the Markets⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Click here for the ticker >>> Get Accelerate Diagnostics News Delivered to You Automatically Sign up to receive the latest news and ratings for AXDX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AXDX vs. The Competition Export to ExcelMetricAccelerate DiagnosticsAnalytical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$41.07M$5.46B$5.20B$8.85BDividend YieldN/A0.44%5.53%4.08%P/E Ratio-0.5711.7479.4715.17Price / Sales3.414.061,246.7687.28Price / CashN/A42.9440.9036.92Price / Book-0.852.507.196.55Net Income-$61.62M$515,312.50$119.54M$226.22M7 Day Performance-11.35%1.55%2.12%3.77%1 Month Performance-8.38%-2.61%-2.43%4.64%1 Year Performance-64.66%-16.01%34.52%29.21% Accelerate Diagnostics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AXDXAccelerate Diagnostics2.4584 of 5 stars$1.64-1.8%$1.00-39.0%-64.7%$41.07M$12.06M-0.57134Negative NewsBNGOBionano Genomics1.3355 of 5 stars$0.22+1.0%$1.50+577.5%-84.6%$22.58M$36.12M-0.09300BLIBerkeley Lights0.7847 of 5 starsN/AN/AN/A$72.04M$78.60M-0.70293HBIOHarvard Bioscience1.5668 of 5 stars$2.22+2.8%N/A-47.8%$96.83M$97.73M-6.55490Positive NewsSEERSeer1.3581 of 5 stars$2.47+3.8%$3.00+21.5%+48.2%$145.66M$16.66M-1.83160KEQUKewaunee Scientific0.9803 of 5 stars$44.50+4.0%N/A+146.1%$127.72M$203.76M6.871,006Positive NewsFEIMFrequency Electronics2.3222 of 5 stars$13.25+0.8%N/A+45.4%$126.76M$57.94M21.19200AKYAAkoya Biosciences1.7047 of 5 stars$2.14+0.9%$5.43+153.7%-49.2%$106.06M$96.63M-1.7990Analyst ForecastMASS908 Devices2.5953 of 5 stars$2.62-4.4%$8.00+205.3%-63.1%$91.23M$50.23M-1.5560OWLTOwlet1.2612 of 5 stars$4.56+0.2%N/A-21.1%$73.14M$54M-1.90106Positive NewsCLIRClearSign Technologies2.3351 of 5 stars$1.21+7.1%$6.00+395.9%+6.3%$60.78M$4.28M-10.2710News CoverageHigh Trading Volume Related Companies and Tools Related Companies BNGO Competitors BLI Competitors HBIO Competitors SEER Competitors KEQU Competitors FEIM Competitors AKYA Competitors MASS Competitors OWLT Competitors CLIR Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:AXDX) was last updated on 11/23/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Accelerate Diagnostics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Accelerate Diagnostics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
